Search Results for "M L Laboritories"
Original Source: ML Labs
ML Laboratories aims to become a significant European pharmaceutical business. ML's primary strategy is to market therapies for serious diseases, where the initial diagnosis and treatment is carried out in hospital and subsequent management takes place at home. ML's current portfolio includes dialysis, respiratory, anticancer, antiviral and pain management products. ML is a subsidiary of Milner Laboratories Limited, an enterprise personally funded by Manchester businessman Kevin Leech to enable it to bring...
Matching PubMed Articles